Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phoenix Biotech Acquisition Corp. Class A (PBAX)
NASDAQ:PBAX
Holding PBAX?
Track your performance easily
PBAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.95 - $12.80
Previous Close$3.01
Volume6.47K
Average Volume (3M)20.04K
Market Cap
$38.77M
Enterprise Value$38.95M
Total Cash (Recent Filing)$475.87K
Total Debt (Recent Filing)$650.00K
Price to Earnings (P/E)―
Beta-0.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding6,769,548
10 Day Avg. Volume7,071
30 Day Avg. Volume20,044
Standard Deviation0.01
R-Squared0.05
Alpha0.00376
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-13.40
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Phoenix Biotech Acquisition Corp. Class A News
PremiumCompany Announcements
Phoenix Biotech’s Strategic Funding and Corporate Actions
PremiumCompany Announcements
Phoenix Biotech Refines Merger Terms with CERo Therapeutics
PremiumCompany Announcements
Phoenix Biotech Shareholders Approve CERo Merger Proposals
Ownership Overview
24.53% Insiders
10.73% Mutual Funds
6.32% Other Institutional Investors
58.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PBAX FAQ
What was Phoenix Biotech Acquisition Corp. Class A’s price range in the past 12 months?
Phoenix Biotech Acquisition Corp. Class A lowest stock price was $2.95 and its highest was $12.80 in the past 12 months.
What is Phoenix Biotech Acquisition Corp. Class A’s market cap?
Currently, no data Available
When is Phoenix Biotech Acquisition Corp. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Phoenix Biotech Acquisition Corp. Class A’s earnings last quarter?
Currently, no data Available
Is Phoenix Biotech Acquisition Corp. Class A overvalued?
According to Wall Street analysts Phoenix Biotech Acquisition Corp. Class A’s price is currently Overvalued.
Does Phoenix Biotech Acquisition Corp. Class A pay dividends?
Phoenix Biotech Acquisition Corp. Class A does not currently pay dividends.
What is Phoenix Biotech Acquisition Corp. Class A’s EPS estimate?
Phoenix Biotech Acquisition Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Phoenix Biotech Acquisition Corp. Class A have?
Phoenix Biotech Acquisition Corp. Class A has 11,929,821 shares outstanding.
What happened to Phoenix Biotech Acquisition Corp. Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Phoenix Biotech Acquisition Corp. Class A?
Among the largest hedge funds holding Phoenix Biotech Acquisition Corp. Class A’s share is Saba Capital Management. It holds Phoenix Biotech Acquisition Corp. Class A’s shares valued at N/A.
---
Phoenix Biotech Acquisition Corp. Class A Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.65%
12-Months-Change
Fundamentals
Return on Equity
-3.03%
Trailing 12-Months
Asset Growth
-95.31%
Trailing 12-Months
Company Description
Phoenix Biotech Acquisition Corp. Class A
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
---